GB0221480D0 - Treatment of anorexia nervosa (AN) and bulimia - Google Patents

Treatment of anorexia nervosa (AN) and bulimia

Info

Publication number
GB0221480D0
GB0221480D0 GBGB0221480.7A GB0221480A GB0221480D0 GB 0221480 D0 GB0221480 D0 GB 0221480D0 GB 0221480 A GB0221480 A GB 0221480A GB 0221480 D0 GB0221480 D0 GB 0221480D0
Authority
GB
United Kingdom
Prior art keywords
bulimia
treatment
anorexia nervosa
nervosa
anorexia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0221480.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laxdale Ltd
Original Assignee
Laxdale Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9944164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB0221480(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laxdale Ltd filed Critical Laxdale Ltd
Priority to GBGB0221480.7A priority Critical patent/GB0221480D0/en
Publication of GB0221480D0 publication Critical patent/GB0221480D0/en
Priority to CNA038251698A priority patent/CN1694694A/zh
Priority to PCT/GB2003/003985 priority patent/WO2004024136A1/en
Priority to JP2004535695A priority patent/JP2006503031A/ja
Priority to YUP-2005/0226A priority patent/RS20050226A/sr
Priority to MXPA05002943A priority patent/MXPA05002943A/es
Priority to US10/528,114 priority patent/US20060135608A1/en
Priority to CA002499142A priority patent/CA2499142A1/en
Priority to TW092125483A priority patent/TW200410682A/zh
Priority to BR0317857-9A priority patent/BR0317857A/pt
Priority to EP03750919A priority patent/EP1556028A1/en
Priority to PL03375726A priority patent/PL375726A1/xx
Priority to HR20050245A priority patent/HRP20050245A2/hr
Priority to AU2003269138A priority patent/AU2003269138A1/en
Priority to RU2005107416/14A priority patent/RU2330653C2/ru
Priority to KR1020057004483A priority patent/KR20050042823A/ko
Priority to NZ538793A priority patent/NZ538793A/en
Priority to ZA200502161A priority patent/ZA200502161B/en
Priority to IS7744A priority patent/IS7744A/is
Priority to NO20051847A priority patent/NO20051847L/no
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0221480.7A 2002-09-16 2002-09-16 Treatment of anorexia nervosa (AN) and bulimia Ceased GB0221480D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB0221480.7A GB0221480D0 (en) 2002-09-16 2002-09-16 Treatment of anorexia nervosa (AN) and bulimia
KR1020057004483A KR20050042823A (ko) 2002-09-16 2003-09-16 신경성 거식증 및 병적기아 치료용에이코사펜타엔산(ｅｐａ)
NZ538793A NZ538793A (en) 2002-09-16 2003-09-16 Eicosapentaenoic acid (EPA) for treating anorexia nervosa (AN) and bulimia
BR0317857-9A BR0317857A (pt) 2002-09-16 2003-09-16 Tratamento de anorexia nervosa (an) e bulimia
EP03750919A EP1556028A1 (en) 2002-09-16 2003-09-16 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia
JP2004535695A JP2006503031A (ja) 2002-09-16 2003-09-16 拒食症（ａｎ）及び過食症を治療するためのエイコサペンタエン酸（ｅｐａ）
YUP-2005/0226A RS20050226A (sr) 2002-09-16 2003-09-16 EIKOSAPENTAENOIČNA KISELINA (EPA) ZA LEČENjE ANOREXIA NERVOSA I BULIMIJE
MXPA05002943A MXPA05002943A (es) 2002-09-16 2003-09-16 Acido eicosapentaenoico (epa) para el tratamiento de la anorexia nerviosa (an) y bulimia.
US10/528,114 US20060135608A1 (en) 2002-09-16 2003-09-16 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia
CA002499142A CA2499142A1 (en) 2002-09-16 2003-09-16 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia
TW092125483A TW200410682A (en) 2002-09-16 2003-09-16 Treatment of anorexia nervosa (an) and bulimia
CNA038251698A CN1694694A (zh) 2002-09-16 2003-09-16 神经性厌食症(an)和贪食症的治疗
PCT/GB2003/003985 WO2004024136A1 (en) 2002-09-16 2003-09-16 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia
PL03375726A PL375726A1 (en) 2002-09-16 2003-09-16 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia
HR20050245A HRP20050245A2 (en) 2002-09-16 2003-09-16 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia
AU2003269138A AU2003269138A1 (en) 2002-09-16 2003-09-16 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia
RU2005107416/14A RU2330653C2 (ru) 2002-09-16 2003-09-16 Эйкозапентаеновая кислота (эпк) для лечения нервно-психической анорексии (на) и булимии
IS7744A IS7744A (is) 2002-09-16 2005-03-15 Eikósapentanó sýra (EPA) til notkunar við meðhöndlun á lystarstoli (AN) og matgræðgi
ZA200502161A ZA200502161B (en) 2002-09-16 2005-03-15 Elcosapentaenoic acid (EPA) for treating anorexia nervosa (AN) and bulimia.
NO20051847A NO20051847L (no) 2002-09-16 2005-04-15 Eikosapentaensyre (EPA) for behandling av anoreksia nevrosa (AN) og bulimi.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0221480.7A GB0221480D0 (en) 2002-09-16 2002-09-16 Treatment of anorexia nervosa (AN) and bulimia

Publications (1)

Publication Number Publication Date
GB0221480D0 true GB0221480D0 (en) 2002-10-23

Family

ID=9944164

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0221480.7A Ceased GB0221480D0 (en) 2002-09-16 2002-09-16 Treatment of anorexia nervosa (AN) and bulimia

Country Status (20)

Country Link
US (1) US20060135608A1 (enExample)
EP (1) EP1556028A1 (enExample)
JP (1) JP2006503031A (enExample)
KR (1) KR20050042823A (enExample)
CN (1) CN1694694A (enExample)
AU (1) AU2003269138A1 (enExample)
BR (1) BR0317857A (enExample)
CA (1) CA2499142A1 (enExample)
GB (1) GB0221480D0 (enExample)
HR (1) HRP20050245A2 (enExample)
IS (1) IS7744A (enExample)
MX (1) MXPA05002943A (enExample)
NO (1) NO20051847L (enExample)
NZ (1) NZ538793A (enExample)
PL (1) PL375726A1 (enExample)
RS (1) RS20050226A (enExample)
RU (1) RU2330653C2 (enExample)
TW (1) TW200410682A (enExample)
WO (1) WO2004024136A1 (enExample)
ZA (1) ZA200502161B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003048831A (ja) 2001-08-02 2003-02-21 Suntory Ltd 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
CA2545190A1 (en) * 2003-11-14 2005-05-26 Mochida Pharmaceutical Co., Ltd. Agent for preventing and treating language disorders
JP4993852B2 (ja) 2004-09-17 2012-08-08 サントリーホールディングス株式会社 ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物
JP5967855B2 (ja) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
JPWO2008081989A1 (ja) 2006-12-28 2010-04-30 サントリーホールディングス株式会社 神経再生剤
US8816110B2 (en) 2007-02-15 2014-08-26 Scf Pharma Inc. Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
EP2121576B1 (en) 2007-02-15 2015-11-11 Centre De Recherche Sur Les Biotechnologies Marine Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
AU2008229604B2 (en) 2007-03-20 2013-05-30 Scf Pharma Inc. Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
SI2443246T1 (en) * 2009-06-15 2018-05-31 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
BR112013020346A2 (pt) * 2011-02-11 2019-09-24 Du Pont concentrado de ácido eicosapentaenoico, produto farmac~eutico, método de elaboração de um concentrado de ácido eicosapentaenoico e uso de óleo microbiano
US9447020B2 (en) 2013-10-31 2016-09-20 Scf Pharma Inc. Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
RU2545988C1 (ru) * 2013-11-12 2015-04-10 Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы Способ лечения хронического запора и функциональной анорексии
WO2019153073A1 (en) 2018-02-07 2019-08-15 Scf Pharma Inc. Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof
WO2019204218A1 (en) * 2018-04-16 2019-10-24 Quadrant Biosciences Inc. Salivary microrna levels in anorexia nervosa provide a liquid biopsy of metabolic and neuropsychiatric status
EP3787614B1 (en) 2018-05-03 2024-07-31 SCF Pharma Inc. Polyunsaturated fatty acid monoglycerides, compositions and use thereof for modulating a microbiota composition of a subject
CN109276262B (zh) * 2018-07-30 2021-01-26 中国科学院心理研究所 一种用于筛选高危进食障碍的检测系统
US12226390B2 (en) 2019-07-21 2025-02-18 Scf Pharma Inc. Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof
AU2021242363A1 (en) * 2020-03-27 2022-11-03 Homeostasis Therapeutics, Limited Method of treatment for anorexia nervosa, bulimia and related clinical syndromes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
GB9901809D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes

Also Published As

Publication number Publication date
AU2003269138A1 (en) 2004-04-30
EP1556028A1 (en) 2005-07-27
RS20050226A (sr) 2007-09-21
NZ538793A (en) 2007-05-31
HRP20050245A2 (en) 2005-10-31
IS7744A (is) 2005-03-15
WO2004024136A1 (en) 2004-03-25
JP2006503031A (ja) 2006-01-26
CA2499142A1 (en) 2004-03-25
RU2330653C2 (ru) 2008-08-10
US20060135608A1 (en) 2006-06-22
TW200410682A (en) 2004-07-01
RU2005107416A (ru) 2006-01-20
ZA200502161B (en) 2005-09-15
BR0317857A (pt) 2005-12-06
CN1694694A (zh) 2005-11-09
PL375726A1 (en) 2005-12-12
NO20051847L (no) 2005-04-15
KR20050042823A (ko) 2005-05-10
MXPA05002943A (es) 2005-06-03

Similar Documents

Publication Publication Date Title
GB0221480D0 (en) Treatment of anorexia nervosa (AN) and bulimia
IL162437A0 (en) Method for limiting use of mobile electronic devices
AU2002321587A1 (en) Treatment of substrates using an electrochemical method
AU2003249366A8 (en) Silk biomaterials and methods of use thereof
IL218909A0 (en) Treatment of diabetes
AU2003253690A8 (en) Silk biomaterials and methods of use thereof
PL378246A1 (pl) Sposób leczenia odrzucania przeszczepu
EP1474445A4 (en) ADIPONECTIN GLYCO-ISOFORMS, AND USES THEREOF
GB0329038D0 (en) Methods of well treatment
PL374003A1 (en) Microwave treatment of ores
AU2003236991A8 (en) Representations of processes
IL158251A0 (en) Treatment of collagen
SG111109A1 (en) Slotted substrate and method of making
EP1576173A4 (en) MODULATORS OF CELL PROLIFERATION
SG111051A1 (en) Maintenance of an electrolyte
EP1575497A4 (en) NEW COMPOSITION AND METHOD FOR TREATING PSORIASIS
AU2003252026A8 (en) Npc1l1 (npc3) and methods of use thereof
AU2003277779A8 (en) Enclosure apparatus and method of fabrication therefor
GB0112216D0 (en) Method of treatment
GB0112235D0 (en) The treatment of anorexia nervosa
AU2003285686A8 (en) Glycoisoforms of adiponectin and uses thereof
EP1450849A4 (en) METHOD FOR TREATING ENDOMETREOSE
AU2003281055A8 (en) Method of inactivating prions
SG96641A1 (en) Method of electro-coating an article
GB2386234B (en) Coding of substrates

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)